Global Chronic Myelogenous Leukemia Treatment Market Research Report 2023

Report ID: 1990827 | Published Date: Jan 2025 | No. of Page: 82 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Chronic Myelogenous Leukemia Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Disease Specific Treatment
        1.2.3 Symptomatic Treatment
    1.3 Market by Application
        1.3.1 Global Chronic Myelogenous Leukemia Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Specialty Pharmacies
        1.3.4 Retail Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Chronic Myelogenous Leukemia Treatment Market Perspective (2017-2028)
    2.2 Chronic Myelogenous Leukemia Treatment Growth Trends by Region
        2.2.1 Chronic Myelogenous Leukemia Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Chronic Myelogenous Leukemia Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Chronic Myelogenous Leukemia Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Chronic Myelogenous Leukemia Treatment Market Dynamics
        2.3.1 Chronic Myelogenous Leukemia Treatment Industry Trends
        2.3.2 Chronic Myelogenous Leukemia Treatment Market Drivers
        2.3.3 Chronic Myelogenous Leukemia Treatment Market Challenges
        2.3.4 Chronic Myelogenous Leukemia Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Chronic Myelogenous Leukemia Treatment Players by Revenue
        3.1.1 Global Top Chronic Myelogenous Leukemia Treatment Players by Revenue (2017-2022)
        3.1.2 Global Chronic Myelogenous Leukemia Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Chronic Myelogenous Leukemia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Chronic Myelogenous Leukemia Treatment Revenue
    3.4 Global Chronic Myelogenous Leukemia Treatment Market Concentration Ratio
        3.4.1 Global Chronic Myelogenous Leukemia Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Chronic Myelogenous Leukemia Treatment Revenue in 2021
    3.5 Chronic Myelogenous Leukemia Treatment Key Players Head office and Area Served
    3.6 Key Players Chronic Myelogenous Leukemia Treatment Product Solution and Service
    3.7 Date of Enter into Chronic Myelogenous Leukemia Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Myelogenous Leukemia Treatment Breakdown Data by Type
    4.1 Global Chronic Myelogenous Leukemia Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Chronic Myelogenous Leukemia Treatment Forecasted Market Size by Type (2023-2028)
5 Chronic Myelogenous Leukemia Treatment Breakdown Data by Application
    5.1 Global Chronic Myelogenous Leukemia Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Chronic Myelogenous Leukemia Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Chronic Myelogenous Leukemia Treatment Market Size (2017-2028)
    6.2 North America Chronic Myelogenous Leukemia Treatment Market Size by Country (2017-2022)
    6.3 North America Chronic Myelogenous Leukemia Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Chronic Myelogenous Leukemia Treatment Market Size (2017-2028)
    7.2 Europe Chronic Myelogenous Leukemia Treatment Market Size by Country (2017-2022)
    7.3 Europe Chronic Myelogenous Leukemia Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Chronic Myelogenous Leukemia Treatment Market Size (2017-2028)
    9.2 Latin America Chronic Myelogenous Leukemia Treatment Market Size by Country (2017-2022)
    9.3 Latin America Chronic Myelogenous Leukemia Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Bristol-Myers Squibb
        11.1.1 Bristol-Myers Squibb Company Detail
        11.1.2 Bristol-Myers Squibb Business Overview
        11.1.3 Bristol-Myers Squibb Chronic Myelogenous Leukemia Treatment Introduction
        11.1.4 Bristol-Myers Squibb Revenue in Chronic Myelogenous Leukemia Treatment Business (2017-2022)
        11.1.5 Bristol-Myers Squibb Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Detail
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Chronic Myelogenous Leukemia Treatment Introduction
        11.2.4 Novartis Revenue in Chronic Myelogenous Leukemia Treatment Business (2017-2022)
        11.2.5 Novartis Recent Development
    11.3 Pfizer
        11.3.1 Pfizer Company Detail
        11.3.2 Pfizer Business Overview
        11.3.3 Pfizer Chronic Myelogenous Leukemia Treatment Introduction
        11.3.4 Pfizer Revenue in Chronic Myelogenous Leukemia Treatment Business (2017-2022)
        11.3.5 Pfizer Recent Development
    11.4 Teva Pharmaceuticals
        11.4.1 Teva Pharmaceuticals Company Detail
        11.4.2 Teva Pharmaceuticals Business Overview
        11.4.3 Teva Pharmaceuticals Chronic Myelogenous Leukemia Treatment Introduction
        11.4.4 Teva Pharmaceuticals Revenue in Chronic Myelogenous Leukemia Treatment Business (2017-2022)
        11.4.5 Teva Pharmaceuticals Recent Development
    11.5 Roche
        11.5.1 Roche Company Detail
        11.5.2 Roche Business Overview
        11.5.3 Roche Chronic Myelogenous Leukemia Treatment Introduction
        11.5.4 Roche Revenue in Chronic Myelogenous Leukemia Treatment Business (2017-2022)
        11.5.5 Roche Recent Development
    11.6 Incyte
        11.6.1 Incyte Company Detail
        11.6.2 Incyte Business Overview
        11.6.3 Incyte Chronic Myelogenous Leukemia Treatment Introduction
        11.6.4 Incyte Revenue in Chronic Myelogenous Leukemia Treatment Business (2017-2022)
        11.6.5 Incyte Recent Development
    11.7 Bio-Path Holdings
        11.7.1 Bio-Path Holdings Company Detail
        11.7.2 Bio-Path Holdings Business Overview
        11.7.3 Bio-Path Holdings Chronic Myelogenous Leukemia Treatment Introduction
        11.7.4 Bio-Path Holdings Revenue in Chronic Myelogenous Leukemia Treatment Business (2017-2022)
        11.7.5 Bio-Path Holdings Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Chronic Myelogenous Leukemia Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Disease Specific Treatment
    Table 3. Key Players of Symptomatic Treatment
    Table 4. Global Chronic Myelogenous Leukemia Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Chronic Myelogenous Leukemia Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Chronic Myelogenous Leukemia Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Chronic Myelogenous Leukemia Treatment Market Share by Region (2017-2022)
    Table 8. Global Chronic Myelogenous Leukemia Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Chronic Myelogenous Leukemia Treatment Market Share by Region (2023-2028)
    Table 10. Chronic Myelogenous Leukemia Treatment Market Trends
    Table 11. Chronic Myelogenous Leukemia Treatment Market Drivers
    Table 12. Chronic Myelogenous Leukemia Treatment Market Challenges
    Table 13. Chronic Myelogenous Leukemia Treatment Market Restraints
    Table 14. Global Chronic Myelogenous Leukemia Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Chronic Myelogenous Leukemia Treatment Market Share by Players (2017-2022)
    Table 16. Global Top Chronic Myelogenous Leukemia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Myelogenous Leukemia Treatment as of 2021)
    Table 17. Ranking of Global Top Chronic Myelogenous Leukemia Treatment Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Chronic Myelogenous Leukemia Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Chronic Myelogenous Leukemia Treatment Product Solution and Service
    Table 21. Date of Enter into Chronic Myelogenous Leukemia Treatment Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Chronic Myelogenous Leukemia Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Chronic Myelogenous Leukemia Treatment Revenue Market Share by Type (2017-2022)
    Table 25. Global Chronic Myelogenous Leukemia Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Chronic Myelogenous Leukemia Treatment Revenue Market Share by Type (2023-2028)
    Table 27. Global Chronic Myelogenous Leukemia Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Chronic Myelogenous Leukemia Treatment Revenue Market Share by Application (2017-2022)
    Table 29. Global Chronic Myelogenous Leukemia Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Chronic Myelogenous Leukemia Treatment Revenue Market Share by Application (2023-2028)
    Table 31. North America Chronic Myelogenous Leukemia Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Chronic Myelogenous Leukemia Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Chronic Myelogenous Leukemia Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Chronic Myelogenous Leukemia Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Chronic Myelogenous Leukemia Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Chronic Myelogenous Leukemia Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Bristol-Myers Squibb Company Detail
    Table 42. Bristol-Myers Squibb Business Overview
    Table 43. Bristol-Myers Squibb Chronic Myelogenous Leukemia Treatment Product
    Table 44. Bristol-Myers Squibb Revenue in Chronic Myelogenous Leukemia Treatment Business (2017-2022) & (US$ Million)
    Table 45. Bristol-Myers Squibb Recent Development
    Table 46. Novartis Company Detail
    Table 47. Novartis Business Overview
    Table 48. Novartis Chronic Myelogenous Leukemia Treatment Product
    Table 49. Novartis Revenue in Chronic Myelogenous Leukemia Treatment Business (2017-2022) & (US$ Million)
    Table 50. Novartis Recent Development
    Table 51. Pfizer Company Detail
    Table 52. Pfizer Business Overview
    Table 53. Pfizer Chronic Myelogenous Leukemia Treatment Product
    Table 54. Pfizer Revenue in Chronic Myelogenous Leukemia Treatment Business (2017-2022) & (US$ Million)
    Table 55. Pfizer Recent Development
    Table 56. Teva Pharmaceuticals Company Detail
    Table 57. Teva Pharmaceuticals Business Overview
    Table 58. Teva Pharmaceuticals Chronic Myelogenous Leukemia Treatment Product
    Table 59. Teva Pharmaceuticals Revenue in Chronic Myelogenous Leukemia Treatment Business (2017-2022) & (US$ Million)
    Table 60. Teva Pharmaceuticals Recent Development
    Table 61. Roche Company Detail
    Table 62. Roche Business Overview
    Table 63. Roche Chronic Myelogenous Leukemia Treatment Product
    Table 64. Roche Revenue in Chronic Myelogenous Leukemia Treatment Business (2017-2022) & (US$ Million)
    Table 65. Roche Recent Development
    Table 66. Incyte Company Detail
    Table 67. Incyte Business Overview
    Table 68. Incyte Chronic Myelogenous Leukemia Treatment Product
    Table 69. Incyte Revenue in Chronic Myelogenous Leukemia Treatment Business (2017-2022) & (US$ Million)
    Table 70. Incyte Recent Development
    Table 71. Bio-Path Holdings Company Detail
    Table 72. Bio-Path Holdings Business Overview
    Table 73. Bio-Path Holdings Chronic Myelogenous Leukemia Treatment Product
    Table 74. Bio-Path Holdings Revenue in Chronic Myelogenous Leukemia Treatment Business (2017-2022) & (US$ Million)
    Table 75. Bio-Path Holdings Recent Development
    Table 76. Research Programs/Design for This Report
    Table 77. Key Data Information from Secondary Sources
    Table 78. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Chronic Myelogenous Leukemia Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Disease Specific Treatment Features
    Figure 3. Symptomatic Treatment Features
    Figure 4. Global Chronic Myelogenous Leukemia Treatment Market Share by Application in 2021 & 2028
    Figure 5. Hospital Pharmacies Case Studies
    Figure 6. Specialty Pharmacies Case Studies
    Figure 7. Retail Pharmacies Case Studies
    Figure 8. Chronic Myelogenous Leukemia Treatment Report Years Considered
    Figure 9. Global Chronic Myelogenous Leukemia Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Chronic Myelogenous Leukemia Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Chronic Myelogenous Leukemia Treatment Market Share by Region: 2021 VS 2028
    Figure 12. Global Chronic Myelogenous Leukemia Treatment Market Share by Players in 2021
    Figure 13. Global Top Chronic Myelogenous Leukemia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Myelogenous Leukemia Treatment as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Chronic Myelogenous Leukemia Treatment Revenue in 2021
    Figure 15. North America Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Chronic Myelogenous Leukemia Treatment Market Share by Country (2017-2028)
    Figure 17. United States Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Chronic Myelogenous Leukemia Treatment Market Share by Country (2017-2028)
    Figure 21. Germany Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Share by Region (2017-2028)
    Figure 29. China Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Chronic Myelogenous Leukemia Treatment Market Share by Country (2017-2028)
    Figure 37. Mexico Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Share by Country (2017-2028)
    Figure 41. Turkey Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Bristol-Myers Squibb Revenue Growth Rate in Chronic Myelogenous Leukemia Treatment Business (2017-2022)
    Figure 44. Novartis Revenue Growth Rate in Chronic Myelogenous Leukemia Treatment Business (2017-2022)
    Figure 45. Pfizer Revenue Growth Rate in Chronic Myelogenous Leukemia Treatment Business (2017-2022)
    Figure 46. Teva Pharmaceuticals Revenue Growth Rate in Chronic Myelogenous Leukemia Treatment Business (2017-2022)
    Figure 47. Roche Revenue Growth Rate in Chronic Myelogenous Leukemia Treatment Business (2017-2022)
    Figure 48. Incyte Revenue Growth Rate in Chronic Myelogenous Leukemia Treatment Business (2017-2022)
    Figure 49. Bio-Path Holdings Revenue Growth Rate in Chronic Myelogenous Leukemia Treatment Business (2017-2022)
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bristol-Myers Squibb
Novartis
Pfizer
Teva Pharmaceuticals
Roche
Incyte
Bio-Path Holdings
Frequently Asked Questions
Chronic Myelogenous Leukemia Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Chronic Myelogenous Leukemia Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Chronic Myelogenous Leukemia Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Citrus Fibre

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More